Vasomune Therapeutics Inc.

Toronto, ON

UEI
ETXLYBADLEM7
CAGE
L0J86
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
180 John St #604, Toronto, ON M5T 1X5, Canada
Website
vasomune.com
Employees
1-10
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Phase i & phase i/II clinical trials for treatment of covid-19 associated ards by AV-001, a novel therapeutic targeting… W81XWH2110834 Defense Health Agency $6,354,825
A novel TIE2 against IV medication for the treatment of ALI/ards in military casualties and civilians W81XWH2010558 Defense Health Agency $2,781,527

Quick answers

Is Vasomune Therapeutics Inc. registered in SAM.gov?

Yes. Vasomune Therapeutics Inc.'s SAM.gov registration is active through September 16, 2027.

What is Vasomune Therapeutics Inc.'s most recent federal award?

Vasomune Therapeutics Inc.'s most recent federal grant award is Phase i & phase i/II clinical trials for treatment of covid-19 associated ards by AV-001, a novel therapeutic targeting… (W81XWH2110834), from Defense Health Agency, on September 1, 2021.

On GovTribe

See Vasomune Therapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login